Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Karuna Therapeutics, Inc. Transaction History

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.

$721 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Apr 10, 2024	BUY	$161.01 - $317.85 $8.11 Million - $16 Million	50,400 New	50,400 $16 Billion
Q2 2023 May 17, 2024	BUY	$176.32 - $240.22 $531,604 - $724,263	3,015 Added 6.36%	50,391 $10.9 Billion
Q1 2023 May 17, 2024	BUY	$161.33 - $204.36 $244,092 - $309,196	1,513 Added 3.3%	47,376 $8.61 Billion
Q4 2022 May 17, 2024	BUY	$191.53 - $236.82 $329,431 - $407,330	1,720 Added 3.9%	45,863 $9.01 Billion
Q3 2022 May 17, 2024	BUY	$123.79 - $277.42 $5.46 Million - $12.2 Million	44,143 New	44,143 $9.93 Billion

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.

Account